Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
Nanophoton Strengthens
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240207642491/en/
The Nanophoton RAMANtouch™ high-speed Raman microscope allows the simultaneous measurement of 400 high-quality Raman spectra for high-resolution spectral imaging (Photo: Business Wire)
Nanophoton augments the molecular microscopy portfolio of the
Professor
Dr.
Financial terms of the transaction were not disclosed. In 2023,
About Nanophoton
Nanophoton was founded in 2003 as the world's only dedicated Raman microscope manufacturer. Nanophoton has developed, manufactured, and sold unique laser-scanning Raman microscopes, including a line-illumination confocal Raman microscope that reduces measurement time by several hundred times and a Raman microscope that employs a unique beam-scanning method based on stochastic process and information theories. Other products Nanophoton has commercialized include the Raman microscopes for deep ultraviolet, for 30-cm wafers, and for long depth of focus imaging. The company also markets unique optical components such as speckle reducers and radial/azimuthal polarizers. Nanophoton has received overwhelming support from many customers, especially in
About
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240207642491/en/
Investors:
Sr. Director, Investor Relations & Corporate Development
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com
Media:
Marketing Manager
T: +49 7243 504 2652
Source: